Home/African Journal of Gastroenterology and Hepatology/Article Record
Peer-Reviewed Article September 30, 2022

Albumin- Bilirubin Score as a Non-Invasive Serum Biomarker for Advanced Liver Fibrosis and Cirrhosis in Egyptian Patients with Chronic Hepatitis C Infection: A Case-Control Study

Are you an author of this work?Link to your sovereign AfriScholar profile
Published in: African Journal of Gastroenterology and Hepatology
Publisher: african journal of gastroenterology and hepatology • Egypt • 2735-5489 • 2735-5497
DOI: https://doi.org/10.21608/ajgh.2022.173503.1019

Abstract

Background: In many health systems, primary care is the main source of health care services. Liver cirrhosis is a silent disease that causes no signs or symptoms until decompensation occurs. Therefore, a simple and readily accessible tool for predicting advanced liver fibrosis and cirrhosis is needed to aid general practitioners in primary care settings. Aim: To explore the predictive performance of Albumin Bilirubin (ALBI) score as a non-invasive serum biomarker for advanced liver fibrosis and cirrhosis. Methods: This case-control study was conducted at Zagazig University Hospitals, Egypt, and comprised 400 participants divided into two equal groups. Group (I): 200 chronic HCV patients with advanced liver fibrosis and cirrhosis [F3-F4], and Group (II): 200 healthy controls. ALBI score was calculated for all study participants. Results: The AUROC for the ALBI score was 0.832 (95% CI: 0.787-0.872) (p-value <0.001), sensitivity= 74.8%, specificity= 80.2%, PPV= 86.8%, NPV =64.6%, and positive likelihood ratio=3.77. The cut-off value to differentiate chronic HCV patients with advanced liver fibrosis and cirrhosis from healthy controls was -2.781. Sub-group analysis of chronic HCV cases showed a statistically significant difference in the mean ALBI score between (F3) and (F4) cases (p-value<0.0001) with an AUROC of 0.654 (p-value=0.028). Conclusion: ALBI score is reliable for predicting advanced liver fibrosis and cirrhosis and could be valuable in primary care.

Download Full Text PDFView at PublisherCrossref RecordCrossref XML

Verified Citation Velocity

Recorded scholarly citations in African and international peer-reviewed literature

2
Total Citations

Citations are continuously tracked and harvested across continental OJS endpoints and OpenAlex feeds.